Vericel (VCEL) Misses Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Vericel Reports Third Quarter 2021 Financial Results
November 9, 2021 7:40 AM ESTThird Quarter Total Net Revenue of $34.5 Million
Year-To-Date 2021 Revenue Increased 38% to $108.6 Million
Conference Call Today at 8:30am Eastern Time
CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the third quarter ended September 30, 2021.
Third Quarter 2021 Financial Highlights
Total net revenue of $34.5 million, compared to $32.3 million in the third quarter of... More